- BNF:
- CNS
- Status:
- Red
- Decision Date:
- August 2018
Comments
RED1,2,3,8: NICE TA533: treating relapsing-remitting multiple sclerosis
RED1,2,3,8: NICE TA585: treating primary progressive multiple sclerosis. (Decision date - July 2019)
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again